Fig. 1From: Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective studyOS and PFS of the total cohort. OS, overall survival; PFS, progression-free survivalBack to article page
